Literature DB >> 10407214

Brain injury, cognitive impairment, and donepezil.

J A Whitlock1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10407214     DOI： 10.1097/00001199-199908000-00010

Source DB:  PubMed          Journal:  J Head Trauma Rehabil        ISSN： 0885-9701            Impact factor:   2.710


× No keyword cloud information.
  8 in total

Review 1.  Relevance of donepezil in enhancing learning and memory in special populations: a review of the literature.

Authors:  J Helen Yoo; Maria G Valdovinos; Dean C Williams
Journal:  J Autism Dev Disord       Date:  2007-01-13

2.  Post-Injury Administration of Galantamine Reduces Traumatic Brain Injury Pathology and Improves Outcome.

Authors:  Jing Zhao; Michael J Hylin; Nobuhide Kobori; Kimberly N Hood; Anthony N Moore; Pramod K Dash
Journal:  J Neurotrauma       Date:  2017-12-18       Impact factor: 5.269

Review 3.  Alterations in Cholinergic Pathways and Therapeutic Strategies Targeting Cholinergic System after Traumatic Brain Injury.

Authors:  Samuel S Shin; C Edward Dixon
Journal:  J Neurotrauma       Date:  2015-06-29       Impact factor: 5.269

4.  Cognitive Impairment Following Traumatic Brain Injury.

Authors:  David B. Arciniegas; Kerri Held; Peter Wagner
Journal:  Curr Treat Options Neurol       Date:  2002-01       Impact factor: 3.598

Review 5.  Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup.

Authors:  Ramon Diaz-Arrastia; Patrick M Kochanek; Peter Bergold; Kimbra Kenney; Christine E Marx; Col Jamie B Grimes; L T C Yince Loh; L T C Gina E Adam; Devon Oskvig; Kenneth C Curley; Wanda Salzer
Journal:  J Neurotrauma       Date:  2014-01-15       Impact factor: 5.269

Review 6.  The cholinergic hypothesis of cognitive impairment caused by traumatic brain injury.

Authors:  David B Arciniegas
Journal:  Curr Psychiatry Rep       Date:  2003-10       Impact factor: 5.285

Review 7.  Treatment of cognitive impairment in multiple sclerosis: is the use of acetylcholinesterase inhibitors a viable option?

Authors:  Christopher Christodoulou; William S MacAllister; Nancy A McLinskey; Lauren B Krupp
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

8.  (-)-Phenserine Ameliorates Contusion Volume, Neuroinflammation, and Behavioral Impairments Induced by Traumatic Brain Injury in Mice.

Authors:  Shih-Chang Hsueh; Daniela Lecca; Nigel H Greig; Jia-Yi Wang; Warren Selman; Barry J Hoffer; Jonathan P Miller; Yung-Hsiao Chiang
Journal:  Cell Transplant       Date:  2019-06-10       Impact factor: 4.064
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.